Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal APH-1105 in mild to moderate Alzheimer's disease
NCT03806478Phase 2Unknown
- Sponsor
- Aphios
- Start
- Jun 2023
- Primary completion
- Sep 2024
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of aph-1105 in Alzheimer's disease (AD), sponsored by Aphios. Status: unknown.
02
Drugs
aph-1105
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT03806478.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03806478.